New water pill formula may reduce bathroom urgency for heart patients
NCT ID NCT06206512
First seen Jan 10, 2026 · Last updated Jun 08, 2026 · Updated 23 times
Summary
This study tested whether a long-acting version of the water pill torsemide could reduce overactive bladder symptoms (like frequent or urgent urination) better than the standard version in people with chronic heart failure. Twenty-four adults aged 50 and older with heart failure and bladder issues took each form for four weeks. The goal was to see if the extended-release pill improved quality of life and reduced daily bathroom trips.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEART FAILURE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Cardiometabolic Research Unit
Dallas, Texas, 75390, United States
Conditions
Explore the condition pages connected to this study.